Nuzenio

Rocket Pharmaceuticals

Rocket Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 13 publisher sources 100/100 entity strength

Latest news

How (RCKT) Movements Inform Risk Allocation Models - Stock Traders DailyStock Traders Daily · Fri, 07 Aug 2026 11:40:01 GMTRCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - StocktwitsStocktwits · Fri, 07 Aug 2026 07:28:04 GMTRocket Pharmaceuticals, Inc. (RCKT) Class Action Lawsuit: Levi - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 05:12:39 GMTRocket Pharmaceuticals, Inc. Revenue Breakdown – BOATS:RCKTW - TradingViewTradingView · Thu, 06 Aug 2026 19:20:22 GMTRocket Pharmaceuticals Inc (RCKT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMTMorgan Stanley Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating, Maintains Target Price $5 - MoomooMoomoo · Tue, 04 Aug 2026 15:33:00 GMTRocket Pharmaceuticals Reports Positive Safety Update for RP-A501 Under Modified Phase 2 Protocol in Danon Disease - BioPharm InternationalBioPharm International · Mon, 03 Aug 2026 17:07:07 GMTRocket Pharmaceuticals Touts Positive Early Safety Data from Revised Genetic Therapy Trial - BenzingaBenzinga · Mon, 03 Aug 2026 16:03:07 GMT

Timeline

Fri, 07 Aug 2026 11:40:01 GMTHow (RCKT) Movements Inform Risk Allocation Models - Stock Traders Daily
Fri, 07 Aug 2026 07:28:04 GMTRCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - Stocktwits
Fri, 07 Aug 2026 05:12:39 GMTRocket Pharmaceuticals, Inc. (RCKT) Class Action Lawsuit: Levi - The National Law Review
Thu, 06 Aug 2026 19:20:22 GMTRocket Pharmaceuticals, Inc. Revenue Breakdown – BOATS:RCKTW - TradingView
Thu, 06 Aug 2026 07:00:00 GMTRocket Pharmaceuticals Inc (RCKT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tue, 04 Aug 2026 15:33:00 GMTMorgan Stanley Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating, Maintains Target Price $5 - Moomoo

Related explainers

AIAI stories cover models, chips, safety, regulation, products, jobs, research, and how automated systems are being used.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Rocket Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.